Apollomics Inc. (APLM) stock
APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
$16.45−0.39 (-2.32%)
Close on Nov 18, 2026Market cap $36.13MP/E –Yield –
Apollomics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $8.50M. The highest annual figure on record is $8.50M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.50M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2022 | Dec 31, 2022 | $0 | – |
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | – |
See a number that looks wrong?